Kurt F. Somerville’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.47M | Sell |
16,735
-6,592
| -28% | -$3.07M | 1.97% | 23 |
|
|
2025
Q4 | $10.6M | Buy |
23,327
+684
| +3% | +$295K | 1.79% | 22 |
|
|
2025
Q3 | $8.87M | Sell |
22,643
-543
| -2% | -$227K | 1.47% | 24 |
|
|
2025
Q2 | $10.3M | Buy |
23,186
+310
| +1% | +$143K | 1.74% | 24 |
|
|
2025
Q1 | $11.1M | Buy |
22,876
+2,484
| +12% | +$1.16M | 1.93% | 24 |
|
|
2024
Q4 | $8.21M | Buy |
20,392
+3,748
| +23% | +$1.74M | 1.38% | 26 |
|
|
2024
Q3 | $7.74M | Buy |
16,644
+4,546
| +38% | +$2.18M | 1.25% | 28 |
|
|
2024
Q2 | $5.67M | Buy |
12,098
+7,300
| +152% | +$3.17M | 0.96% | 29 |
|
|
2024
Q1 | $2.01M | Buy |
4,798
+2,623
| +121% | +$1.11M | 0.34% | 42 |
|
|
2023
Q4 | $885K | Buy |
2,175
+750
| +53% | +$277K | 0.17% | 54 |
|
|
2023
Q3 | $496K | Sell |
1,425
-75
| -5% | -$26.2K | 0.1% | 72 |
|
|
2023
Q2 | $528K | Hold |
1,500
| – | – | 0.1% | 72 |
|
|
2023
Q1 | $473K | Hold |
1,500
| – | – | 0.09% | 78 |
|
|
2022
Q4 | $433K | Hold |
1,500
| – | – | 0.08% | 82 |
|
|
2022
Q3 | $434K | Hold |
1,500
| – | – | 0.09% | 82 |
|
|
2022
Q2 | $423K | Hold |
1,500
| – | – | 0.08% | 85 |
|
|
2022
Q1 | $391K | Hold |
1,500
| – | – | 0.06% | 89 |
|
|
2021
Q4 | $329K | Hold |
1,500
| – | – | 0.05% | 105 |
|
|
2021
Q3 | $272K | Hold |
1,500
| – | – | 0.04% | 103 |
|
|
2021
Q2 | $302K | Hold |
1,500
| – | – | 0.05% | 97 |
|
|
2021
Q1 | $322K | Hold |
1,500
| – | – | 0.05% | 91 |
|
|
2020
Q4 | $355K | Hold |
1,500
| – | – | 0.06% | 86 |
|
|
2020
Q3 | $408K | Sell |
1,500
-40
| -3% | -$11K | 0.07% | 81 |
|
|
2020
Q2 | $447K | Sell |
1,540
-8
| -0.5% | -$2.17K | 0.08% | 80 |
|
|
2020
Q1 | $368K | Hold |
1,548
| – | – | 0.08% | 77 |
|
|
2019
Q4 | $339K | Hold |
1,548
| – | – | 0.06% | 78 |
|
|
2019
Q3 | $262K | Hold |
1,548
| – | – | 0.05% | 88 |
|
|
2019
Q2 | $284K | Hold |
1,548
| – | – | 0.06% | 85 |
|
|
2019
Q1 | $285K | Hold |
1,548
| – | – | 0.06% | 94 |
|
|
2018
Q4 | $257K | Hold |
1,548
| – | – | 0.06% | 94 |
|
|
2018
Q3 | $298K | Hold |
1,548
| – | – | 0.06% | 96 |
|
|
2018
Q2 | $263K | Hold |
1,548
| – | – | 0.06% | 93 |
|
|
2018
Q1 | $252K | Hold |
1,548
| – | – | 0.06% | 97 |
|
|
2017
Q4 | $232K | Hold |
1,548
| – | – | 0.05% | 101 |
|
|
2017
Q3 | $235K | Buy |
+1,548
| New | +$233K | 0.05% | 98 |
|
Other funds holding VRTX
VCM
VPM
Kurt F. Somerville's VRTX Position: Q1 2026 in Review
Kurt F. Somerville reduced its Vertex Pharmaceuticals (VRTX) stake by 28% in Q1 2026, selling an estimated $3.07M and leaving 16,735 shares worth $7.47M. The position accounts for 1.97% of the portfolio, ranked #23.
Kurt F. Somerville first reported a position in VRTX in Q3 2017 and has held it in 35 quarters since. The position peaked at $11.1M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Kurt F. Somerville held 16,735 shares of Vertex Pharmaceuticals worth $7.47M as of Q1 2026.
- Kurt F. Somerville sold 6,592 Vertex Pharmaceuticals shares in Q1 2026, an estimated $3.07M.
- Vertex Pharmaceuticals made up 1.97% of Kurt F. Somerville's portfolio in Q1 2026, its #23 holding.
- Kurt F. Somerville first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 35 quarters since.
- Kurt F. Somerville's Vertex Pharmaceuticals position peaked at $11.1M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Kurt F. Somerville's 13F filing for Q1 2026, filed 8 May 2026.